[1]刘德忠,王彬,闫东,等.胰腺癌综合治疗现状及其价值[J].介入放射学杂志,2008,(06):451.
　LIU Dezhong,WANG Bin,YAN Dong,et al.The current status and evaluation of comprehensive therapy of pancreatic carcinoma[J].journal interventional radiology,2008,(06):451.
点击复制

胰腺癌综合治疗现状及其价值()

PDF下载中关闭

分享到：

《介入放射学杂志》[ISSN:1008-794X/CN:31-1796/R]

卷:
期数:
2008年06期
页码:
451
栏目:
讲座
出版日期:
2008-06-15

文章信息/Info

Title:
The current status and evaluation of comprehensive therapy of pancreatic carcinoma
作者:
刘德忠; 王彬; 闫东; 等
１０００２１北京中国医学科学院肿瘤医院影像诊断科（刘德忠、闫东、李槐）；江苏省徐州市第一人民医院介入科（王彬）
Author(s):
LIU De－zhong; WANG Bin; YAN Dong; LI Huai．
Department of Radiology，Cancer Hospital of Chinese Academy of Medical Science，Beijing１００２１０，China
关键词:
胰腺癌; 综合治疗
分类号:
R７３５.９
文献标志码:
C
摘要:
任何单一疗法治疗胰腺癌都难以获得理想的疗效。目前，可切除胰腺癌的治疗仍以根治性切除为主。放射治疗与手术联合应用，可提高手术切除率，减少肿瘤扩散；术中放疗可以缓解疼痛，提高生存率；对术后辅助放化疗的作用仍有争议。区域性化疗理论上有诸多优势，但仍需数据支持。物理治疗和生物治疗在胰腺癌的治疗中也已经得到广泛的重视。但只有建立以手术切除为主，联合放疗、化疗、物理及生物治疗的综合治疗体系，才有可能根本改变治疗现状，显著提高长期生存率，并改善生活质量。介入治疗作为重要的姑息治疗方法之一，近年来得到了长足的发展。

参考文献/References:

［１］Jemal A，Siegel R，Ward E，et al．Cancer Statistics，２００７［J］．Cancer J Clin，２００７，５７：４３－６６．
［２］Wagner M，Redaelli C，Lietz M，et al．Curative resection is the single most important factor determining outcome in patients with pancreatic adenocarcinoma ［J］．Br J Surg，２００４，９１：５８６－５９４．
［３］Makowiec F，Post S，Saeger HD，et al．Current practice patterns in pancreatic surgery：results of a multi－institutional analysis of seven large surgical departments in germany with１４５４pancreatic head resections，１９９９to２００４（German Advanced Surgical Treatment Study Group）［J］．J Gastrointest Surg，２００５，９：１０８０－１０８７．
［４］Ujiki MB，Talamonti MS．Surgical management of pancreatic cancer［J］．Semin Radiat Oncol，２００５，１５：２１８－２２５．
［５］Imamura M，FACS，Doi R，et al．A randomized multicenter trial comparing resection and radio chemotherapy for resectable locally invasive pancreatic cancer［J］．Surgery，２００４，１３６：１００３－１０１１．
［６］Rubin P，Williams JP．临床肿瘤学［M］．第８版．北京：人民卫生出版社，２００２：７６８．
［７］Tao KS，Lu YG，Dou KF．Palliative operation procedures for pancreatic head carcinoma ［J］．Hepatobil Panc Dis Internat，２００２，１：１３３－１３６．
［８］Kahl S，Zimmermann S，Pross M，et al．Endoscopic biliary drainage in patients with pancreatic cancer［J］．Zentralblatt Chirurgie，２００３，１２８：４０６－４１０．
［９］Lillemoe KD，Cameron JL，Kaufman HS ，et al．Chemical splanchnicectomy in patients with unresectable pancreatic cancer．A prospective randomized trial［J］．Ann Surg，１９９３，２１７：４４７－４５５．
［１０］Polati E，Finco G，Gottin L，et al．Prospective randomized double－blind trail of neurolytic celiac plexus block in patients with pancreatic cancer［J］．Br J Surg，１９９８，８５：１９９－２０１．
［１１］Evans DB，Wolff RA，Crane CG．Neoadjuvant strategies for pancreatic cancer［J］．Oncology，２００１，１５：７２７－７３７．
［１２］Cunha AS，Rault A，Laurent C，et al．Surgical resection after radio chemotherapy patients with unresectable adenocarcinoma of the pancreas［J］．J Am Coll Surg，２００５，２０１：３５９－３６５．
［１３］Hoffman JP，Lipsitz S，Pisansky T，et al．PhaseⅡtrial of preoperative radiation therapy and chemotherapy for patients with localized，respectable adenocarcinoma of the pancreas：an eastern cooperative oncology group study［J］．J Clin Oncol，１９９８，１６：３１７－３２３．
［１４］Snady H，Bruckner H，Cooperman A，et al．Survival advantage of combined chemo－radiotherapy compared with resection as the initial treatment of patients with regional pancreatic carcinoma ：an outcomes trial［J］．Cancer，２０００，８９：３１４－３２７．
［１５］Ammori JB，Colletti LM，Zalupski MM，et al．Surgical resection following radiation therapy with concurrent gemcitabine in patients with previously unresectable adenocarcinoma of thepancreas［J］．J Gastrointest Surg，２００３，７：７６６－７７２．［１６］Peterz T，Nori D，Hilaris B，et al．Treatment of primary unre－sectable carcinoma of the pancreas with I １２５ implantation［J］．Int J Radiat Oncol，Biol，Phys，１９８９，１７：９３１－９３５．
［１７］Wang DM，Liu YH，Yu SP，et al．Intraoperative I １２５ Brach therapy combined with chemotherapy for pancreatic cancer［J］．Chin J Oncol，２００４，２６：４３３－４３６．
［１８］Ding A，Tong SX，Jin DY，et al．Treatment of unresectable carcinoma of the pancreas with I １２５ implantation and I １２５ ＋gemcitabine［J］．J Hepatopancreatobil Surg，２００４，１６：１９－２２．
［１９］Kalser MH，Ellenberg SS．Pancreatic cancer：adjuvant com－bined radiation and chemotherapy following curative resection［J］．Arch Surg，１９８５，１２０：８９９－９０３．
［２０］Klinkenbijl JH，Jeeekel J，Sahmoud T，et al．Adjuvant radio－therapy and５－fluorouracil after curative resection of cancer of the pancreas and perampullary region－phase III trial of the EORTC Gastrointestinal Tract Cancer Cooperative Group［J］．Ann Surg１９９９，２３０：７７６－７８２．
［２１］Neoptolemos JP，Stocken DD，Friess H，et al．A randomized trial of chemo radiotherapy and chemotherapy after resection of pancreatic cancer［J］．N Engl J Med，２００４，３５０：１２００－１２１０．
［２２］Shinchi H，Takao S，Noma H，et al．Length and quality of survival after external－beam radiotherapy with concurrent continuous５－fluorouracil infusion for locally unresectable pancreatic cancer［J］．Internat J Radiat Oncol Biol Phys，２００２，５３：１４６－１５０．
［２３］Burris HA，Moore MJ ，Andersen J，et al．Improvements in survival and clinical benefit with gemcitabine as first－line therapy for patients with advanced pancreas cancer：a randomized trial［J］．J Clin Oncol，１９９７，１５：２４０３－２４１３．
［２４］Storniolo AM，Enas NH，Brown CA，et al．An investigational new drug treatment program for patients with gemcitabine：Results for over３０００patients with pancreatic carcinoma ［J］．Cancer，１９９９，８５：１２６１－１２６８．
［２５］Louvet C，Labianca R，Hammel P，et al．Gemcitabine in combination with oxaliplatin compared with gemcitabine alone in locally advanced or metastatic pancreatic cancer：results of a GERCOR and GISCAD phase III trial［J］．J Clin Oncol，２００５，２３：３５０９－３５１６．
［２６］Colucci G，Giuliani F，Gebbia V，et al．Gemcitabine alone or with cisplatin for the treatment of patients with locally advanced and／or metastatic pancreatic carcinoma ：A prospective，randomized phase III study of the Group Oncology dell 'Italia Meridionale［J］．Cancer，２００２，９４：９０２－９１０．
［２７］Tempero M，Plunkett W，Haperen VR，et al．Randomized phase II comparison of dose－intense gemcitabine：thirty－minute infusion and fixed dose rate infusion in patients with pancreatic adenocarcinoma ［J］．J Clin Oncol，２００３，２１：３４０２－３４０８．
［２８］Thomford NR，Chandnani PC，Taha AM，et al．Anatomic characteristics of the pancreatic arteries：adiologic observation and their clinical significance［J］．Am J Surg，１９８６，１５１：６９０－６９３．
［２９］Mitsutsuji M，Suzuki Y，Iwanaga Y，et al．An experimental study on the pharmacokinetics of５－fluorouracil regional chemotherapy for pancreatic cancer［J］．Ann Surg Oncol，２００３，１０：５４６－５５０．
［３０］Shamseddine AI ，Khalifeh MJ ，Mourad FH，et al．Comparative pharmacokinetics and metabolic pathway of gemcitabine during intravenous and intra－arterial delivery in unresectable pancreatic cancer patients［J］．Clin pharmacokinet，２００５，４４：９５７－９６７．
［３１］Fu DL，Ni QX，Yu XJ ，et al．Regional intra arterial infusion chemotherapy for pancreatic cancer：an experimental study［J］．Nat Med J China，２００２，８２，３７１－３７５．
［３２］Hayashibe A，Kameyama M，Shinbo M，et al．Clinical results on intra－arterial adjuvant chemotherapy for prevention of liver metastasis following curative resection of pancreatic cancer［J］．Ann Surg Oncol，２００７，１４：１９０－１９４．
［３３］Papachristou E，Link KH，Schoenberg MH，et al．Regional celiac artery infusion in the adjuvant treatment of pancreatic cancer［J］．Anticancer Res，２００３，２３（２A）：８３１－８３４．
［３４］Cantore M，Pederzoli P，Cornalba G，et al．Intra－arterial chemotherapy for unresectable pancreatic cancer［J］．Ann Oncol，２０００，１１：５６９－５７３．
［３５］Cantore M，Fiorentini G，Luppi G，et al．Gemcitabine versus FLEC regimen given intra－arterially to patients with unresectable pancreatic cancer：a prospective，randomized phaseⅢtrial of the Italian Society for Integrated Locoregional Therapy in Oncology［J］．J Chemother，２００４，１６：５８９－５９４．
［３６］Mambrini A，Sanguinetti F，Pacetti P，et al．Intra－arterial infusion of５－fluorouracil，leucovorin，epirubicin and carboplatin（FLEC regimen）in unresectable pancreatic cancer：results of a ten－year experience［J］．In Vivo，２００６，２０（６A）：７５１－７５５．
［３７］Takamori H，Kanemitsu K，Tsuji T，et al．５－Fluorouracil intra－arterial infusion combined with systemic gemcitabine for unresectable pancreatic cancer［J］．Pancreas，２００５，３：２２３－２２６．
［３８］Hong GB，Zhou JY，Xu LF，et al．Meta－analysis on comparative study of curative effect between interventional therapy and conventional systemic venous chemotherapy in moderate and advanced pancreatic cancer［J］．J Practical Radiol，２００４，２０：３５０－３５３．
［３９］Gu YZ，Wang GM，Xia HS ，et al．Application of high intensity focused ultrasound in treating４５cases of carcinoma of pancreas［J］．J Shanghai Medica（University），２００４，３１：１３５－１３７．

相似文献/References:

[1]杜学明,许建辉,郎建华,等.多学科技术联合１２５Ⅰ治疗癌梗阻性黄疸[J].介入放射学杂志,2008,(05):346.
　DU Xueming,XU Jianhui,LANG Jianhua,et al.Combination of multi－disciplinary techniques with１２５Ⅰseeds in treating malignant obstructive jaundice[J].journal interventional radiology,2008,(06):346.
[2]王彬,闫东,刘德忠,等.胰腺癌不同治疗模式的疗效分析[J].介入放射学杂志,2008,(06):404.
　WANG Bin,YANG Dong,LIU Dezhong,et al.Analysis of different therapeutic programs for patients with pancreatic carcinoma[J].journal interventional radiology,2008,(06):404.
[3]李槐,刘德忠,闫东.胰腺癌的介入诊疗[J].介入放射学杂志,2008,(06):381.
　LI Huai,LIU Dezhong,YAN Dong.Interventional therapy for pancreatic carcinoma[J].journal interventional radiology,2008,(06):381.
[4]宋恬,殷士蒙,孙荣跃,等.探讨介入治疗对晚期胰腺癌的疗效[J].介入放射学杂志,2008,(06):411.
　SONG Tian,YIN Shimeng,SUN Rongyue,et al.The efficacy discussion of interventional therapy for advanced pancreatic carcinoma[J].journal interventional radiology,2008,(06):411.
[5]王彬,闫东,刘德忠,等.影响胰腺癌疗效的多因素分析[J].介入放射学杂志,2008,(06):414.
　WANG Bin,YAN Dong,LIU Dezhong,et al.Prognostic factors in patients with pancreatic carcinoma[J].journal interventional radiology,2008,(06):414.
[6]陆健,郑云峰,张欢,等.CT导引下植入１２５I粒子治疗１９例晚期胰腺癌的疗效观察[J].介入放射学杂志,2010,(07):550.
　LU Jian,ZHENG Yunfeng,ZHANG Huan,et al.CT－guided radioactive１２５I－seed implantation for the treatment of pancreatic carcinoma ：a clinical observation of １９cases[J].journal interventional radiology,2010,(06):550.
[7]刘卫东,苗善巧,李铁钢,等.胰腺癌介入治疗初步经验[J].介入放射学杂志,1997,(03):182.
[8]张大海.胰周血管的螺旋CT血管造影[J].介入放射学杂志,1998,(03):130.
[9]王忠.下肢深静脉血栓形成的病因及其综合治疗[J].介入放射学杂志,2005,(06):660.
　WANG Zhong.The etiology of deep venous thrombosis in the lower extremities and its synthetic therapies[J].journal interventional radiology,2005,(06):660.
[10]席名未,谢宗贵,李健,等.经皮穿刺胰管引流及支架置入术在胰腺癌姑息治疗中的应用[J].介入放射学杂志,2007,(05):323.
　XI Ming-wei,XIE Zong-gui,LI Jian,et al.Application of percutaneous pancreatic duct draining and stenting in palliative treatment of pancreatic carcinoma[J].journal interventional radiology,2007,(06):323.

备注/Memo

备注/Memo:
收稿日期：２００８－０４－０３
更新日期/Last Update: 2008-06-15